Xiaopeng Ai

1.5k total citations · 1 hit paper
25 papers, 1.1k citations indexed

About

Xiaopeng Ai is a scholar working on Molecular Biology, Ophthalmology and Pharmacology. According to data from OpenAlex, Xiaopeng Ai has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Ophthalmology and 4 papers in Pharmacology. Recurrent topics in Xiaopeng Ai's work include Berberine and alkaloids research (3 papers), Retinal Diseases and Treatments (3 papers) and Polysaccharides and Plant Cell Walls (3 papers). Xiaopeng Ai is often cited by papers focused on Berberine and alkaloids research (3 papers), Retinal Diseases and Treatments (3 papers) and Polysaccharides and Plant Cell Walls (3 papers). Xiaopeng Ai collaborates with scholars based in China. Xiaopeng Ai's co-authors include Xianli Meng, Ya Hou, Xiaobo Wang, Xiaorui Chen, Jinrong Bai, Yi Zhang, Yunsen Zhang, Ce Tang, Peiling Yu and Xianrong Lai and has published in prestigious journals such as Scientific Reports, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Xiaopeng Ai

23 papers receiving 1.1k citations

Hit Papers

Gallic acid: Pharmacological activities and molecular mec... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopeng Ai China 14 391 148 141 134 117 25 1.1k
Ya Hou China 20 520 1.3× 122 0.8× 132 0.9× 132 1.0× 101 0.9× 45 1.3k
Liang Feng China 18 635 1.6× 126 0.9× 166 1.2× 159 1.2× 135 1.2× 89 1.3k
Su Jung Hwang South Korea 16 541 1.4× 141 1.0× 163 1.2× 115 0.9× 126 1.1× 44 1.3k
Yajun Bai China 18 608 1.6× 96 0.6× 106 0.8× 97 0.7× 101 0.9× 84 1.3k
Wenwen Jin China 18 457 1.2× 76 0.5× 176 1.2× 68 0.5× 130 1.1× 74 1.3k
Young-Beob Yu South Korea 14 419 1.1× 182 1.2× 147 1.0× 154 1.1× 111 0.9× 49 1.0k
Se‐Eun Park South Korea 23 460 1.2× 158 1.1× 217 1.5× 71 0.5× 132 1.1× 59 1.2k
Maria Chaudhry United States 9 543 1.4× 113 0.8× 169 1.2× 174 1.3× 145 1.2× 38 1.6k
Jiazhen Wu China 19 436 1.1× 100 0.7× 101 0.7× 188 1.4× 100 0.9× 39 934
Chia‐Cheng Li Taiwan 26 552 1.4× 91 0.6× 179 1.3× 283 2.1× 116 1.0× 51 1.3k

Countries citing papers authored by Xiaopeng Ai

Since Specialization
Citations

This map shows the geographic impact of Xiaopeng Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Ai more than expected).

Fields of papers citing papers by Xiaopeng Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopeng Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Ai. The network helps show where Xiaopeng Ai may publish in the future.

Co-authorship network of co-authors of Xiaopeng Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopeng Ai. A scholar is included among the top collaborators of Xiaopeng Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopeng Ai. Xiaopeng Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ai, Xiaopeng, et al.. (2025). Research progress in the extraction, purification, structural features, biological activities, and structure-activity relationships from Prunella vulgaris polysaccharides. International Journal of Biological Macromolecules. 307(Pt 2). 141957–141957. 1 indexed citations
2.
Yu, Peiling, et al.. (2025). Extraction methods, structural features and bioactivity diversity of polysaccharides from the genus Chrysanthemum: A review. International Journal of Biological Macromolecules. 293. 139423–139423. 6 indexed citations
4.
5.
Wang, Jing, et al.. (2025). Microbial short chain fatty acids: Effective histone deacetylase inhibitors in immune regulation (Review). International Journal of Molecular Medicine. 57(1). 1–29. 2 indexed citations
6.
Yu, Peiling, Jing Wang, Jia Liu, et al.. (2024). Preparation techniques, structural features, and bioactivities of Eucommia ulmoides polysaccharides: A review. International Journal of Biological Macromolecules. 275(Pt 2). 133686–133686. 12 indexed citations
7.
Wang, Jing, et al.. (2024). Gut microbiota as a key regulator of intestinal mucosal immunity. Life Sciences. 345. 122612–122612. 41 indexed citations
8.
Wang, Jing, et al.. (2024). Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells. International Immunopharmacology. 143(Pt 3). 113570–113570. 17 indexed citations
9.
Ai, Xiaopeng, Peiling Yu, Xiangyu Li, et al.. (2023). Polysaccharides from Spirulina platensis: Extraction methods, structural features and bioactivities diversity. International Journal of Biological Macromolecules. 231. 123211–123211. 56 indexed citations
10.
Ai, Xiaopeng, et al.. (2022). Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway. Journal of Ethnopharmacology. 296. 115453–115453. 41 indexed citations
11.
Ai, Xiaopeng, Xing Dong, Ying Guo, et al.. (2021). Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment. Purinergic Signalling. 17(2). 229–240. 4 indexed citations
12.
Ai, Xiaopeng, Peiling Yu, Li‐Xia Peng, et al.. (2021). Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases. Frontiers in Pharmacology. 12. 762654–762654. 109 indexed citations
14.
Li, Ning, Ke Chen, Jinrong Bai, et al.. (2020). Tibetan medicine Duoxuekang ameliorates hypobaric hypoxia-induced brain injury in mice by restoration of cerebrovascular function. Journal of Ethnopharmacology. 270. 113629–113629. 20 indexed citations
15.
Ai, Xiaopeng, Peiling Yu, Ya Hou, et al.. (2020). A review of traditional Chinese medicine on treatment of diabetic retinopathy and involved mechanisms. Biomedicine & Pharmacotherapy. 132. 110852–110852. 52 indexed citations
16.
Bai, Jinrong, Yunsen Zhang, Ce Tang, et al.. (2020). Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomedicine & Pharmacotherapy. 133. 110985–110985. 480 indexed citations breakdown →
17.
Wang, Xiaobo, Ya Hou, Xiaopeng Ai, et al.. (2020). Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development. Biomedicine & Pharmacotherapy. 132. 110822–110822. 44 indexed citations
18.
Ai, Xiaopeng, Ya Hou, Xiaobo Wang, et al.. (2019). Amelioration of dry eye syndrome in db/db mice with diabetes mellitus by treatment with Tibetan Medicine Formula Jikan Mingmu Drops. Journal of Ethnopharmacology. 241. 111992–111992. 21 indexed citations
20.
Lai, Xianrong, Dong Tong, Xiaopeng Ai, et al.. (2018). Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract. Scientific Reports. 8(1). 16707–16707. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026